Clinical Trials
6 trialsNCT07493109 2026-03-25
Chidamide for Maintenance Treatment of HBV-infected Diffuse DLBCL in Patients Initially Treated With R-CHOP
The First Hospital of Jilin University
Phase 3 Recruiting
NCT04539119 2020-09-04
Entecavir and Tenofovir Versus Entecavir in Lymphoma Patients With Positive HBV DNA
Ruijin Hospital
Phase 3 Unknown
NCT01765231 2017-01-10
Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma
Peking University
Phase 4 Unknown
NCT01768195 2017-01-10
Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy
Peking University
Phase 4 Unknown
NCT00931229 2016-11-09
Incidence of Hepatitis B Reactivation in Non-Hodgkin's Lymphoma Patients
National Health Research Institutes, Taiwan
Phase NA Unknown
NCT01914744 2013-08-02
Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL
Fudan University
Phase 2 Unknown